1 The e ect of the i.c.v. administration of pertussis toxin (PTX) and antisense oligodeoxynucleotide directed against the a subunit of di erent Gi-proteins (anti-Gia1, anti-Gia2, anti-Gia3) on amnesia induced by morphine was evaluated in the mouse passive avoidance test. 2 The administration of morphine (6 ± 10 mg kg71 i.p.) immediately after the training session produced amnesia that was prevented by PTX (0.25 mg per mouse i.c.v.) administered 7 days before the passive avoidance test. 3 Anti-Gia1 (6.25 mg per mouse i.c.v.) and anti-Gia3 (12.5 mg per mouse i.c.v.), administered 18 and 24 h before the training session, prevented the morphine amnesia. By contrast, pretreatment with anti-Gia2 (3.12 ± 25 mg per mouse i.c.v.) never modi®ed the impairment of memory processes induced by morphine. 4 At the highest e ective doses, none of the compounds used impaired motor coordination, as revealed by the rota rod test, nor modi®ed spontaneous motility and inspection activity, as revealed by the hole board test. 5 These results suggest the important role played by Gi1 and Gi3 protein subtypes in the transduction mechanism involved in the impairment of memory processes produced by morphine.

Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits / N. GALEOTTI; C. GHELARDINI; A. BARTOLINI. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - STAMPA. - 133:(2001), pp. 267-274. [10.1038/sj.bjp.0704081]

Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits.

GALEOTTI, NICOLETTA;GHELARDINI, CARLA;BARTOLINI, ALESSANDRO
2001

Abstract

1 The e ect of the i.c.v. administration of pertussis toxin (PTX) and antisense oligodeoxynucleotide directed against the a subunit of di erent Gi-proteins (anti-Gia1, anti-Gia2, anti-Gia3) on amnesia induced by morphine was evaluated in the mouse passive avoidance test. 2 The administration of morphine (6 ± 10 mg kg71 i.p.) immediately after the training session produced amnesia that was prevented by PTX (0.25 mg per mouse i.c.v.) administered 7 days before the passive avoidance test. 3 Anti-Gia1 (6.25 mg per mouse i.c.v.) and anti-Gia3 (12.5 mg per mouse i.c.v.), administered 18 and 24 h before the training session, prevented the morphine amnesia. By contrast, pretreatment with anti-Gia2 (3.12 ± 25 mg per mouse i.c.v.) never modi®ed the impairment of memory processes induced by morphine. 4 At the highest e ective doses, none of the compounds used impaired motor coordination, as revealed by the rota rod test, nor modi®ed spontaneous motility and inspection activity, as revealed by the hole board test. 5 These results suggest the important role played by Gi1 and Gi3 protein subtypes in the transduction mechanism involved in the impairment of memory processes produced by morphine.
2001
133
267
274
N. GALEOTTI; C. GHELARDINI; A. BARTOLINI
File in questo prodotto:
File Dimensione Formato  
57.BJP 2001.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Open Access
Dimensione 326.64 kB
Formato Adobe PDF
326.64 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/309334
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact